[HTML][HTML] Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma
PA Zucali - Journal of thoracic disease, 2018 - ncbi.nlm.nih.gov
Malignant pleural mesothelioma (MPM) is a disease with a poor prognosis due to its
aggressive nature. The management of patients with MPM is controversial. Considering that …
aggressive nature. The management of patients with MPM is controversial. Considering that …
Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma
PA Zucali - Journal of thoracic disease, 2018 - pubmed.ncbi.nlm.nih.gov
Malignant pleural mesothelioma (MPM) is a disease with a poor prognosis due to its
aggressive nature. The management of patients with MPM is controversial. Considering that …
aggressive nature. The management of patients with MPM is controversial. Considering that …
Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma.
PA Zucali - Journal of Thoracic Disease, 2018 - europepmc.org
Malignant pleural mesothelioma (MPM) is a disease with a poor prognosis due to its
aggressive nature. The management of patients with MPM is controversial. Considering that …
aggressive nature. The management of patients with MPM is controversial. Considering that …
[HTML][HTML] Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma
PA Zucali - Journal of Thoracic Disease, 2018 - jtd.amegroups.org
Malignant pleural mesothelioma (MPM) is a disease with a poor prognosis due to its
aggressive nature. The management of patients with MPM is controversial. Considering that …
aggressive nature. The management of patients with MPM is controversial. Considering that …
[PDF][PDF] Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma
PA Zucali - 2018 - cdn.amegroups.cn
Malignant pleural mesothelioma (MPM) is a disease with a poor prognosis due to its
aggressive nature. The management of patients with MPM is controversial. Considering that …
aggressive nature. The management of patients with MPM is controversial. Considering that …
Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma
PA Zucali - JOURNAL OF THORACIC DISEASE, 2018 - iris.hunimed.eu
Malignant pleural mesothelioma (MPM) is a disease with a poor prognosis due to its
aggressive nature. The management of patients with MPM is controversial. Considering that …
aggressive nature. The management of patients with MPM is controversial. Considering that …
[引用][C] Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma
PA Zucali - Journal of Thoracic Disease, 2018 - cir.nii.ac.jp
Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma.
PA Zucali - Journal of Thoracic Disease, 2018 - europepmc.org
Malignant pleural mesothelioma (MPM) is a disease with a poor prognosis due to its
aggressive nature. The management of patients with MPM is controversial. Considering that …
aggressive nature. The management of patients with MPM is controversial. Considering that …
Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma
PA Zucali - Journal of Thoracic Disease, 2018 - jtd.amegroups.org
Malignant pleural mesothelioma (MPM) is a disease with a poor prognosis due to its
aggressive nature. The management of patients with MPM is controversial. Considering that …
aggressive nature. The management of patients with MPM is controversial. Considering that …